ReWalk has strong quarter, year
ReWalk Robotics of Marlborough reported a 283 percent jump in revenue, to $1.5 million, for the fourth quarter of 2014 compared with the same quarter in 2013.
The rise resulted from higher placements of ReWalk robotic exoskeleton systems during the quarter, the company said. Thirty-six systems were placed in the quarter, compared with six for the quarter a year earlier. The skeletons help people with spinal cord injury walk.
The company also reported Thursday that total revenue for 2014 increased to $4.0 million compared to $1.6 million in 2013.
ReWalk, which also has offices in Israel and Germany, said in a statement that 2014 was a landmark year highlighted by two significant events. The first was gaining Food and Drug Administration clearance for its robotic exoskeletons, the only such system that can be legally marketed in the U.S.
The second, said CEO Larry Jasinski, was that “we significantly strengthened the company’s balance sheet through our successful initial public offering, increasing our financial flexibility."
WBJ Web Partners
Most Recent
Most Recent
0 Comments